Alk-abelló A/s
Clinical trials sponsored by Alk-abelló A/s, explained in plain language.
-
Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
Disease control CompletedThis study looks back at health records from over 46,000 people in Denmark and Sweden with allergic rhinitis (hay fever), some of whom also have asthma. It compares those who used SQ sublingual immunotherapy (SLIT) tablets — a daily tablet placed under the tongue containing grass…
Sponsor: ALK-Abelló A/S • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Peanut allergy pill shows promise in early trial
Disease control CompletedThis study tested a daily tablet placed under the tongue (SLIT) containing peanut protein to help people with peanut allergy tolerate small amounts of peanut. The trial included 209 adults, teens, and children ages 4 to 65. Researchers measured how many participants could safely …
Phase: PHASE1, PHASE2 • Sponsor: ALK-Abelló A/S • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Study reveals Real-World allergy care for kids
Knowledge-focused CompletedThis study observed how private pediatricians in France manage allergic rhinitis (hay fever) in children under 18. Over 1,000 children participated, and researchers collected data on current treatment practices, including how many kids might be eligible for allergy immunotherapy.…
Sponsor: ALK-Abelló A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC